Please assess the completion status of the following clinical trial:

Trial Title: PCP Use of a Gene Expression Test (Corus CAD or ASGES) in Coronary Artery Disease Diagnosis

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Stable chest pain, typical or atypical angina or anginal equivalent~2. The patient has signed the appropriate Institutional Review Board approved Informed Consent Form.~Exclusion Criteria:~1. History of myocardial infarction~2. Current Myocardial infarction (MI) or acute coronary syndrome.~3. Current New York Heart Association (NYHA) class III or IV congestive heart failure symptoms.~4. Any previous coronary revascularization.~5. Any individuals with :~   * Diabetes~  * Suspected unstable angina~  * Systemic infections~  * Systemic inflammatory conditions~6. Any individuals currently taking:~   * Steroids~  * Immunosuppressive agents~  * Chemotherapeutic agents~7. Any Major Surgery within 2 months

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- All subjects (Type: None): Subjects are enrolled at multiple participating primary care practices. The main inclusion criterion for enrollment is the occurrence of chest pain (or anginal equivalent) in a patient without known significant coronary artery disease (CAD) or a history of prior myocardial infarction.

Based on this trial design, predict the completion outcome and termination type (if applicable).